HeartFlow plans a $100M IPO to fund R&D and new products despite financial risks. Read about its prospects, challenges, and ...

This briefing covers Heartflow's upcoming IPO aiming for a $1.32 billion valuation, research linking artificial sweeteners to ...

The company reported revenue of $37.2 million in the first quarter, up 39% year over year, but said it has faced challenges ...

Medical technology company Heartflow said on Friday it was targeting a valuation of up to $1.32 billion in its U.S. initial ...

The company, which sells software for creating 3D heart models, plans to offer 12.5 million shares at a range of $15 to $17 ...

Toledo's profit forecast boost, Heartflow's IPO plans, research linking artificial sweeteners to less effective cancer ...

Like waves crashing on the beach, med-tech IPOs keep on coming. Heartflow Inc. set terms for its IPO on Aug. 1, offering 12.5 ...

--HeartFlow, Inc., the leader in revolutionizing precision heart care, today announced the Centers for Medicare& Medicaid Services have established a national payment rate of $930.34 for the ...

Heartflow said it would have about 79.5 million shares outstanding after the IPO, assuming an exercise of the overallotment option, for a market capitalization topping $1.27 billion at the $16-a-share ...

HeartFlow uses medical imaging to create more complete models of patients' cardiovascular systems; it's a non-invasive technology aimed at improving treatment and reducing unnecessary procedures ...

HeartFlow Inc. has raised a fresh funding round that puts the company’s valuation over $1.5 billion. and Baillie Gifford led the a $240 million Series E, with participation from existing ...

The HeartFlow is a special kind of CT scan of the heart. It analyzes something called fractional flow reserve. The doctors send the CT images to a company in California for a special computer program.